DONGGUAN QILANG TECHNOLOGY CO., LTD – Trademark Portfolio

Entity Type: 16

DONGGUAN QILANG TECHNOLOGY CO., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 28 (Toys & Sporting Goods) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include BOISIAXIM. The owner is based in DONGGUAN CITY.

ROOM 1102, BUILDING A, ZHONGQIAO BUILDING, NO. 162 QIFENG ROAD

XINGTANG COMMUNITY, GUANCHENG SUBDISTRICT

DONGGUAN CITY 523000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BOISIAXIM
BOISIAXIM
Registered 2023

Trademark Classifications

DONGGUAN QILANG TECHNOLOGY CO., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does DONGGUAN QILANG TECHNOLOGY CO., LTD have?

DONGGUAN QILANG TECHNOLOGY CO., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does DONGGUAN QILANG TECHNOLOGY CO., LTD file in?

DONGGUAN QILANG TECHNOLOGY CO., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 28 (Toys & Sporting Goods). Class 28 covers games and playthings; gymnastic and sporting articles; decorations for christmas trees.

What are DONGGUAN QILANG TECHNOLOGY CO., LTD's most well-known trademarks?

DONGGUAN QILANG TECHNOLOGY CO., LTD's registered trademark portfolio includes well-known marks such as BOISIAXIM. These are among 1 currently registered trademark in the portfolio.

What is DONGGUAN QILANG TECHNOLOGY CO., LTD's trademark registration success rate?

DONGGUAN QILANG TECHNOLOGY CO., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.